Beta-agonists have chemical structures, similar to the naturally occurring catecholamines, adrenaline and noradrenaline. They were originally produced for the treatment of respiratory diseases such as asthma. Beta-agonists facilitate the use of fats rather than glucose as a fuel source. Therefore, meat production is increased while fat deposition is inhibited. This improves the meat: fat ratio of animals and leads to the production of higher quality meat at lower cost. There is a risk that residues of Beta-agonists may be present in meat products, which may be harmful to the consumer. The use of Beta-agonists as growth promoters has been banned in most countries. Consequently, it is important that abuse of these compounds is monitored.
|Beta Agonists||0.30 (Urine)||Clenbuterol|